Stevanato Group S.p.A STVN
NYSE STVN
$20.92 +0.68 (+3.36%)
As of: Sep 10, 2026 · 3:59 PM EDT

Stevanato Group S.p.A (STVN) Capital Expenditures (2020 - 2026)

Stevanato Group S.p.A's (STVN) quarterly Capital Expenditures came in at -$67.0 million in Q2 2026, down 2.75% year-over-year from -$68.9 million in Q2 2025, and up 13.61% quarter-over-quarter from -$77.6 million in Q1 2026.

Analysis

Stevanato Group S.p.A (STVN) Capital Expenditures (2020 - 2026) Analysis & Trends

Stevanato Group S.p.A (STVN) has reported Capital Expenditures for 7 consecutive years, with -$67.0 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Capital Expenditures fell 2.75% year-over-year to -$67.0 million in Q2 2026; TTM through Jun 2026 was -$302.8 million, a 6.96% decrease from a year earlier, with the FY2025 full-year figure at -$307.0 million, up 5.05% from the prior year.
  • Capital Expenditures was -$67.0 million for Q2 2026 at Stevanato Group S.p.A, up from -$77.6 million in the prior quarter.
  • Over five years, Capital Expenditures peaked at -$40.7 million in Q3 2022 and troughed at -$142.9 million in Q3 2023.
  • A 5-year average of -$82.6 million and a median of -$75.8 million in 2025 frame the typical range for Capital Expenditures.
  • Across the five-year window, Capital Expenditures plunged 250.89% in 2023 and jumped 65.84% in 2024, its largest moves.
  • Over 5 years, Capital Expenditures stood at -$69.3 million in 2022, then decreased by 27.36% to -$88.2 million in 2023, then declined by 7.67% to -$95.0 million in 2024, then slipped by 9.42% to -$103.9 million in 2025, then surged by 35.54% to -$67.0 million in 2026.
  • The last three Capital Expenditures figures came in at -$67.0 million (Q2 2026), -$77.6 million (Q1 2026), and -$103.9 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Becton Dickinson 48.41 Bn 47.55 Bn 2.32 Bn 143.00 Mn
2 Medline 27.78 Bn 25.10 Bn 2.22 Bn 111.00 Mn
3 West Pharmaceutical Services 24.42 Bn 23.98 Bn 329.20 Mn 43.20 Mn
4 Baxter International 12.49 Bn 10.34 Bn 1.03 Bn 116.00 Mn
5 Stevanato Group S.p.A 5.70 Bn 5.59 Bn 100.91 Mn -67.01 Mn
6 Acme United 235.29 Mn 230.25 Mn 26.69 Mn 1.07 Mn
7 Rockwell Medical 31.39 Mn 6.60 Mn 3.24 Mn 617,000.00
8 Retractable Technologies 21.15 Mn -18.72 Mn 190,852.00 29,823.00
9 United Health Products 8.85 Mn 8.82 Mn - -
10 Cuprina Holdings (Cayman) 7.88 Mn 4.76 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -67.01 Mn
Mar 31, 2026 -77.57 Mn
Dec 31, 2025 -103.95 Mn
Sep 30, 2025 -54.26 Mn
Jun 30, 2025 -65.21 Mn
Mar 31, 2025 -74.04 Mn
Dec 31, 2024 -95.00 Mn
Sep 30, 2024 -48.83 Mn
Jun 30, 2024 -74.00 Mn
Mar 31, 2024 -109.22 Mn
Dec 31, 2023 -88.23 Mn
Sep 30, 2023 -142.93 Mn
Jun 30, 2023 -100.40 Mn
Mar 31, 2023 -137.10 Mn
Dec 31, 2022 -69.27 Mn
Sep 30, 2022 -40.73 Mn
Jun 30, 2022 -78.96 Mn
Mar 31, 2022 -59.19 Mn
Dec 31, 2021 -41.53 Mn
Sep 30, 2021 -32.20 Mn